Evidence map›Paper›PMID 41546761›Full record

SynthesisCancer causes & control : CCC2026

Early menarche and breast cancer risk: a systematic review and meta-analysis of 74 case-control studies.

Fui-Ling Voon, Edmund Ui-Hang Sim

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fui-Ling VoonFaculty of Resource Science and Technology, University Malaysia Sarawak, 94300, Kota Samarahan, Sarawak, Malaysia. voonfuiling@gmail.com.
Edmund Ui-Hang SimFaculty of Resource Science and Technology, University Malaysia Sarawak, 94300, Kota Samarahan, Sarawak, Malaysia. uhsim@unimas.my.

Funding

Sarawak Digital Economy Corporation (SDEC) Bhd.'s Translational Research Grant Programme IRG/F07/SDEC/85162/2022
6 · The paper itself

Abstract

purposeEarly menarche is a known risk factor for breast cancer, as established by the Collaborative Group on Hormonal Factors in Breast Cancer in a 2012 reanalysis of data from forty-seven global epidemiological studies. Given recent changes in the average age at menarche, it is important to re-evaluate this association in the context of the past decade. This meta-analysis aimed to examine the relationship between early menarche, particularly before age 13, and female breast cancer risk by analyzing recently published observational studies and exploring this relationship across different regions of the world.

methodsCase-control studies published between January 2014 and February 2025 were systematically searched in PubMed, ScienceDirect, Scopus, and Google Scholar. Early menarche was defined as < 13 years. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using common-effect models when heterogeneity was low (I

resultsOverall, results of the present meta-analyses show an increased association between menarche age < 13 and the risk of female breast cancer (OR = 1.15 [95% CI: 1.08 - 1.24]). Also, an increased association with breast cancer risk was found in the subgroup of menarche age < 12 (OR = 1.27 [95% CI: 1.09 - 1.48]). Lower OR was found in subgroup of menarche age ≥ 13 (OR = 0.89 [95% CI: 0.85 - 0.94]). For the geographical region subgroups, increased associations between menarche age < 13 and risk of breast cancer were found in Europe (OR = 1.15 [95% CI: 1.07 - 1.25]), North America (OR = 1.07 [95% CI: 1.03 - 1.11]), Oceania (OR = 1.15 [95% CI: 1.02 - 1.30]), and West Asia (OR = 1.70 [95% CI: 1.15 - 2.52]). Both population-based and hospital-based study designs demonstrated higher ORs for the association between menarche age < 13 and the risk of female breast cancer.

conclusionsThis meta-analysis found a modest but statistically significant association between menarche before age 13 and increased breast cancer risk worldwide, while women who experienced menarche at age 13 or older had a lower risk. The association varied by region, with relatively higher odds observed in West Asia, Europe, Oceania, and North America. These results indicate an association rather than causation and are limited by the observational nature of the included studies.

Indexed as

Breast NeoplasmsMenarcheAdolescentAge FactorsCase-Control StudiesFemaleHumansRisk FactorsBreast neoplasmsCancer riskEarly pubertyEpidemiologyFemale adolescentMenarche age

Identifiers

PMID41546761
PMCPMC12812095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.